Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment
NCT ID: NCT00692133
Last Updated: 2010-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
250 participants
OBSERVATIONAL
2008-03-31
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stabilized out-patients
* Treated with the same oral antipsychotic at least in the last month
Exclusion Criteria
* Administration of a depot antipsychotic medication
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca Pharmaceuticals
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Angel L Montejo
Role: STUDY_CHAIR
University of Salamanca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Vitoria-Gasteiz, Alava, Spain
Research Site
Palma, Balearic Islands, Spain
Research Site
Gavà, Barcelona, Spain
Research Site
Burgos, Burgos, Spain
Research Site
Puerto Real, Cadiz, Spain
Research Site
Santander, Cantabria, Spain
Research Site
Castellon, Castellon, Spain
Research Site
Ceuta, Ceuta, Spain
Research Site
A Coruña, Coruna, Spain
Research Site
Atarfe, Granada, Spain
Research Site
Granada, Granada, Spain
Research Site
Arrasate / Mondragón, Guipuzcoa, Spain
Research Site
Donostia / San Sebastian, Guipuzcoa, Spain
Research Site
Linares, Jaen, Spain
Research Site
León, Leon, Spain
Research Site
Alcobendas, Madrid, Spain
Research Site
Madrid, Madrid, Spain
Research Site
Parla, Madrid, Spain
Research Site
Estepona, Malaga, Spain
Research Site
Málaga, Malaga, Spain
Research Site
Murcia, Murcia, Spain
Research Site
Elizondo, Navarre, Spain
Research Site
Pamplona, Navarre, Spain
Research Site
Tudela, Navarre, Spain
Research Site
Pontevedra, Pontevedra, Spain
Research Site
Oviedo, Principality of Asturias, Spain
Research Site
Salamanca, Salamanca, Spain
Research Site
Tarragona, Tarragona, Spain
Research Site
Alzira, Valencia, Spain
Research Site
Sagunto, Valencia, Spain
Research Site
Galdako, Vizcaya, Spain
Research Site
Zamudio, Vizcaya, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NES-DUM-2007/2
Identifier Type: -
Identifier Source: org_study_id